TerrAscend Corp. (TSNDF)
(Delayed Data from OTC)
$1.80 USD
+0.05 (2.86%)
Updated May 16, 2024 03:59 PM ET
4-Sell of 5 4
B Value A Growth F Momentum B VGM
Brokerage Reports
0 items in cart
TerrAscend Corp. [TSNDF]
Reports for Purchase
Showing records 1 - 9 ( 9 total )
Company: TerrAscend Corp.
Industry: Medical - Products
Company: TerrAscend Corp.
Industry: Medical - Products
Transitory MD Cultivation Issue and Underutilized Manufacturing Investments a Speedbump
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: TerrAscend Corp.
Industry: Medical - Products
Company: TerrAscend Corp.
Industry: Medical - Products
Q323 Results a Blowout. Operational Turnaround From 2022 Now on Full Display.
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: TerrAscend Corp.
Industry: Medical - Products
Company: TerrAscend Corp.
Industry: Medical - Products
Cannabis Industry Update: August 2023 Perfromance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: TerrAscend Corp.
Industry: Medical - Products
Results and Guidance Above Estimates, And We Sense Some Conservatism in the Guide. Rapidly Improving Operating Momentum.
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: TerrAscend Corp.
Industry: Medical - Products
Company: TerrAscend Corp.
Industry: Medical - Products
|